___

• 1. Shah RU, Henry TD, Rutten-Ramos S, Garberich RF, Tighiouart M, Bairey Merz CN. Increasing percutaneous coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity. JACC Cardiovasc Interv 2015; 8: 139-146.
• 2. Windecker S, Hernández-Antolín RA, Stefanini GG, Wijns W, Zamorano JL. Management of ST-elevation myocardial infarction according to European and American guidelines. EuroIntervention 2014; 10: 23-31.
• 3. Schellings DA, Adiyaman A, Giannitsis E, Hamm C, Suryapranata H, Ten Berg JM, Hoorntje JC, Van’t Hof AW. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score. J Am Heart Assoc 2014; 3: e001089.
• 4. Raposeiras-Roubín S, Abu-Assi E, Cabanas-Grandío P, AgraBermejo RM, Gestal-Romarí S, Pereira-López E, FandiñoVaquero R, Álvarez-Álvarez B, Cambeiro C, RodríguezCordero M et al. Walking beyond the GRACE (Global Registry of Acute Coronary Events) model in the death risk stratification during hospitalization in patients with acute coronary syndrome: what do the AR-G (ACTION [Acute Coronary Treatment and Intervention Outcomes Network] Registry and GWTG [Get With the Guidelines] Database), NCDR (National Cardiovascular Data Registry), and EuroHeart Risk Scores Provide? JACC Cardiovasc Interv 2012; 5: 1117-1125.
• 5. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of Infarcting Myocardium Early II trial substudy. Circulation 2000; 102: 2031-2037.
• 6. Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T et al. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘All-Comers’ LEADERS trial. Circ Cardiovasc Interv 2011; 4: 47-56.
• 7. Capodanno D, Marcantoni C, Ministeri M, Dipasqua F, Zanoli L, Rastelli S, Mangiafico S, Sanfilippo M, Romano G, Tamburino C. Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention. Int J Cardiol 2013; 168: 396-402.
• 8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
• 9. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133.
• 10. Majidi M, Kosinski AS, Al-Khatib SM, Smolders L, Cristea E, Lansky AJ, Stone GW, Mehran R, Gibbons RJ, Crijns HJ et al. Implications of ventricular arrhythmia “bursts” with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury “downstream of downstream”. Eur Heart J Acute Cardiovasc Care 2015; 4: 51-59.
• 11. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow flow and no-reflow. Chest 2002; 22: 1322– 1332.
• 12. Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, BlömstromLundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
• 13. Brkovic V, Dobric M, Beleslin B, Giga V, Vukcevic V, Stojkovic S, Stankovic G, Nedeljkovic MA, Orlic D, Tomasevic M et al. Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Int J Cardiovasc Imaging 2013; 29: 1215-1228.
• 14. Méndez-Eirín E, Flores-Ríos X, García-López F, Pérez-Pérez AJ, Estévez-Loureiro R, Piñón-Esteban P, Aldama-López G, Salgado-Fernández J, Calviño-Santos RA, Vázquez Rodríguez JM et al. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI. Rev Esp Cardiol (Engl Ed) 2012; 65: 227-233.
• 15. Akgun T, Oduncu V, Bitigen A, Karabay CY, Erkol A, Kocabay G, Ozveren O, Yildiz A, Cimen AO, Kirma C. Baseline SYNTAX score and long-term outcome in patients with STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin Appl Thromb Hemost 2015; 21: 712-719.
• 16. Biondi-Zoccai G, Romagnoli E, Castagno D, Sheiban I, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L et al. Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score. EuroIntervention 2012; 8: 359-367.
• 17. Pyxaras SA, Mangiacapra F, Wijns W, Di Serafino L, De Vroey F, Toth G, Sinagra G, De Bruyne B, Heyndrickx GR, Barbato E. ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation. Catheter Cardiovasc Interv 2014; 83: 1067-1073.
• 18. Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G. The ACEF score as predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention. Int J Cardiol 2013; 168: 4386-4387.